Stewart Alan Factor - Publications

Affiliations: 
Emory University, Atlanta, GA 
Area:
Movement Disorders

205 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Espay AJ, Guskey MT, Norton JC, Coate B, Vizcarra JA, Ballard C, Factor SA, Friedman JH, Lang AE, Larsen NJ, Andersson C, Fredericks D, Weintraub D. Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medications. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30387904 DOI: 10.1002/mds.27488  0.4
2017 Fox SH, Metman LV, Nutt JG, Brodsky M, Factor SA, Lang AE, Pope LE, Knowles N, Siffert J. Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28370447 DOI: 10.1002/mds.26976  0.4
2016 McGarry A, McDermott M, Kieburtz K, de Blieck EA, Beal F, Marder K, Ross C, Shoulson I, Gilbert P, Mallonee WM, Guttman M, Wojcieszek J, Kumar R, LeDoux MS, Jenkins M, ... ... Factor SA, et al. A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. Neurology. PMID 27913695 DOI: 10.1212/WNL.0000000000003478  0.64
2016 Frank S, Testa CM, Stamler D, Kayson E, Davis C, Edmondson MC, Kinel S, Leavitt B, Oakes D, O'Neill C, Vaughan C, Goldstein J, Herzog M, Snively V, ... ... Factor SA, et al. Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial. Jama. 316: 40-50. PMID 27380342 DOI: 10.1001/jama.2016.8655  1
2016 Factor SA, Hatcher-Martin JM, Morse AS, Nocera JR, Revuelta GJ. Freezing of gait that disappears: Should there be rest before rehab? Parkinsonism & Related Disorders. PMID 27103479 DOI: 10.1016/j.parkreldis.2016.04.010  1
2016 Comella CL, Perlmutter JS, Jinnah HA, Waliczek TA, Rosen AR, Galpern WR, Adler CA, Barbano RL, Factor SA, Goetz CG, Jankovic J, Reich SG, Rodriguez RL, Severt WL, Zurowski M, et al. Clinimetric testing of the comprehensive cervical dystonia rating scale. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26971359 DOI: 10.1002/mds.26534  1
2016 Carvalho JO, Long JD, Westervelt HJ, Smith MM, Bruce JM, Kim JI, Mills JA, Paulsen JS, The Predict-Hd Investigators And Coordinators Of The Huntington Study Group. The impact of oculomotor functioning on neuropsychological performance in Huntington disease. Journal of Clinical and Experimental Neuropsychology. 38: 217-226. PMID 26745770 DOI: 10.1080/13803395.2015.1101054  1
2016 Sampat R, Young S, Rosen A, Bernhard D, Millington D, Factor S, Jinnah HA. Potential mechanisms for low uric acid in Parkinson disease Journal of Neural Transmission. 1-6. DOI: 10.1007/s00702-015-1503-4  1
2015 Mata IF, Jang Y, Kim CH, Hanna DS, Dorschner MO, Samii A, Agarwal P, Roberts JW, Klepitskaya O, Shprecher DR, Chung KA, Factor SA, Espay AJ, Revilla FJ, Higgins DS, et al. The RAB39B p.G192R mutation causes X-linked dominant Parkinson's disease. Molecular Neurodegeneration. 10: 50. PMID 26399558 DOI: 10.1186/s13024-015-0045-4  1
2015 O'Brien CF, Jimenez R, Hauser RA, Factor SA, Burke J, Mandri D, Castro-Gayol JC. NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1681-7. PMID 26346941 DOI: 10.1002/mds.26330  1
2015 Long JD, Paulsen JS. Multivariate prediction of motor diagnosis in Huntington's disease: 12 years of PREDICT-HD. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26340420 DOI: 10.1002/mds.26364  1
2015 Mata IF, Leverenz JB, Weintraub D, Trojanowski JQ, Chen-Plotkin A, Van Deerlin VM, Ritz B, Rausch R, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Peterson-Hiller AL, Goldman JG, Stebbins GT, et al. GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26296077 DOI: 10.1002/mds.26359  1
2015 Schuff N, Wu IW, Buckley S, Foster ED, Coffey CS, Gitelman DR, Mendick S, Seibyl J, Simuni T, Zhang Y, Jankovic J, Hunter C, Tanner CM, Rees L, Factor S, et al. Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26260437 DOI: 10.1002/mds.26325  1
2015 Matsui JT, Vaidya JG, Wassermann D, Kim RE, Magnotta VA, Johnson HJ, Paulsen JS. Prefrontal cortex white matter tracts in prodromal Huntington disease. Human Brain Mapping. 36: 3717-32. PMID 26179962 DOI: 10.1002/hbm.22835  1
2015 Simuni T, Caspell-Garcia C, Coffey C, Chahine LM, Lasch S, Oertel WH, Mayer G, Högl B, Postuma R, Videnovic A, Amara AW, Marek K. Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1371-81. PMID 26095202 DOI: 10.1002/mds.26248  1
2015 Kim JI, Long JD, Mills JA, McCusker E, Paulsen JS. Multivariate Clustering of Progression Profiles Reveals Different Depression Patterns in Prodromal Huntington Disease. Neuropsychology. PMID 26011117 DOI: 10.1037/neu0000199  1
2015 Kelly VE, Johnson CO, McGough EL, Shumway-Cook A, Horak FB, Chung KA, Espay AJ, Revilla FJ, Devoto J, Wood-Siverio C, Factor SA, Cholerton B, Edwards KL, Peterson AL, Quinn JF, et al. Association of cognitive domains with postural instability/gait disturbance in Parkinson's disease. Parkinsonism & Related Disorders. 21: 692-7. PMID 25943529 DOI: 10.1016/j.parkreldis.2015.04.002  1
2015 Weintraub D, Simuni T, Caspell-Garcia C, Coffey C, Lasch S, Siderowf A, Aarsland D, Barone P, Burn D, Chahine LM, Eberling J, Espay AJ, Foster ED, Leverenz JB, Litvan I, et al. Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 919-27. PMID 25737166 DOI: 10.1002/mds.26170  1
2015 Srivatsal S, Cholerton B, Leverenz JB, Wszolek ZK, Uitti RJ, Dickson DW, Weintraub D, Trojanowski JQ, Van Deerlin VM, Quinn JF, Chung KA, Peterson AL, Factor SA, Wood-Siverio C, Goldman JG, et al. Cognitive profile of LRRK2-related Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 728-33. PMID 25650144 DOI: 10.1002/mds.26161  1
2015 Shaikh AG, Mewes K, DeLong MR, Gross RE, Triche SD, Jinnah HA, Boulis N, Willie JT, Freeman A, Alexander GE, Aia P, Butefisch CM, Esper CD, Factor SA. Temporal profile of improvement of tardive dystonia after globus pallidus deep brain stimulation. Parkinsonism & Related Disorders. 21: 116-9. PMID 25465373 DOI: 10.1016/j.parkreldis.2014.11.013  0.52
2015 Musso M, Westervelt HJ, Long JD, Morgan E, Woods SP, Smith MM, Lu W, Paulsen JS, Cross S, Ryan P, Epping EA, Chiu E, Preston J, Goh A, Antonopoulos S, ... ... Factor SA, et al. Intra-individual variability in prodromal Huntington disease and its relationship to genetic burden Journal of the International Neuropsychological Society. 21: 8-21. DOI: 10.1017/S1355617714001076  1
2015 Silver MR, Factor SA. VPA, lithium, amiodarone, and other non-DA Medication-Induced Movement Disorders. 131-140. DOI: 10.1017/CBO9781107588738.013  1
2014 Factor SA, Scullin MK, Sollinger AB, Land JO, Wood-Siverio C, Zanders L, Freeman A, Bliwise DL, McDonald WM, Goldstein FC. Cognitive correlates of hallucinations and delusions in Parkinson's disease. Journal of the Neurological Sciences. 347: 316-21. PMID 25466695 DOI: 10.1016/j.jns.2014.10.033  1
2014 Factor SA, Scullin MK, Sollinger AB, Land JO, Wood-Siverio C, Zanders L, Freeman A, Bliwise DL, Goldstein FC. Freezing of gait subtypes have different cognitive correlates in Parkinson's disease. Parkinsonism & Related Disorders. 20: 1359-64. PMID 25446341 DOI: 10.1016/j.parkreldis.2014.09.023  1
2014 Hamza TH, Hill-Burns EM, Scott WK, Vance JM, Factor SA, Zabetian CP, Payami H. Glutamate receptor gene GRIN2A, coffee, and Parkinson disease. Plos Genetics. 10: e1004774. PMID 25411979 DOI: 10.1371/journal.pgen.1004774  1
2014 Factor SA, Jankovic J. Randomized trial of IV valproate vs metoclopramide vs ketorolac for acute migraine. Neurology. 83: 1388-9. PMID 25288700 DOI: 10.1212/01.wnl.0000455698.16732.0a  1
2014 Hauser RA, Isaacson S, Clinch T, Ellenbogen A, Silver D, Struck L, Gil R, Pappert E, Jankovic J, Goldstein S, LeWitt P, Hull K, Thomas M, Danisi F, Factor S, et al. Randomized, placebo-controlled trial of trimethobenzamide to control nausea and vomiting during initiation and continued treatment with subcutaneous apomorphine injection Parkinsonism and Related Disorders. 20: 1171-1176. PMID 25239603 DOI: 10.1016/j.parkreldis.2014.08.010  1
2014 Mata IF, Leverenz JB, Weintraub D, Trojanowski JQ, Hurtig HI, Van Deerlin VM, Ritz B, Rausch R, Rhodes SL, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Peterson AL, Espay AJ, et al. APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease. Jama Neurology. 71: 1405-12. PMID 25178429 DOI: 10.1001/jamaneurol.2014.1455  1
2014 Chen X, Huddleston DE, Langley J, Ahn S, Barnum CJ, Factor SA, Levey AI, Hu X. Simultaneous imaging of locus coeruleus and substantia nigra with a quantitative neuromelanin MRI approach. Magnetic Resonance Imaging. 32: 1301-6. PMID 25086330 DOI: 10.1016/j.mri.2014.07.003  1
2014 Burdick DJ, Cholerton B, Watson GS, Siderowf A, Trojanowski JQ, Weintraub D, Ritz B, Rhodes SL, Rausch R, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Srivatsal S, Edwards KL, et al. People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1258-64. PMID 25073717 DOI: 10.1002/mds.25924  1
2014 Bliwise DL, Scullin MK, Factor SA. Internal consistency of the University of Michigan RBD Questionnaire. Journal of Neurology. 261: 1439-41. PMID 24916829 DOI: 10.1007/s00415-014-7392-x  1
2014 Goldman SM, Kamel F, Ross GW, Jewell SA, Marras C, Hoppin JA, Umbach DM, Bhudhikanok GS, Meng C, Korell M, Comyns K, Hauser RA, Jankovic J, Factor SA, Bressman S, et al. Peptidoglycan recognition protein genes and risk of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1171-80. PMID 24838182 DOI: 10.1002/mds.25895  1
2014 Paulsen JS, Long JD, Johnson HJ, Aylward EH, Ross CA, Williams JK, Nance MA, Erwin CJ, Westervelt HJ, Harrington DL, Bockholt HJ, Zhang Y, McCusker EA, Chiu EM, Panegyres PK, et al. Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study. Frontiers in Aging Neuroscience. 6: 78. PMID 24795630 DOI: 10.3389/fnagi.2014.00078  1
2014 Revuelta GJ, Montilla J, Benatar M, Freeman A, Wichmann T, Jinnah HA, Delong MR, Factor SA. An ¹⁸F-FDG PET study of cervical muscle in parkinsonian anterocollis. Journal of the Neurological Sciences. 340: 174-7. PMID 24725739 DOI: 10.1016/j.jns.2014.03.023  1
2014 Moonen AJ, Wijers A, Leentjens AF, Christine CW, Factor SA, Juncos J, Lyness JM, Marsh L, Panisset M, Pfeiffer R, Rottenberg D, Serrano Ramos C, Shulman L, Singer C, Slevin J, et al. Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease. Parkinsonism & Related Disorders. 20: 644-6. PMID 24679737 DOI: 10.1016/j.parkreldis.2014.02.025  1
2014 Hill-Burns EM, Wissemann WT, Hamza TH, Factor SA, Zabetian CP, Payami H. Identification of a novel Parkinson's disease locus via stratified genome-wide association study. Bmc Genomics. 15: 118. PMID 24511991 DOI: 10.1186/1471-2164-15-118  1
2014 Factor SA, Jankovic J. Editorial: Neurotherapeutics of movement disorders. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 11: 3-5. PMID 24366609 DOI: 10.1007/s13311-013-0241-2  1
2014 Cloud LJ, Zutshi D, Factor SA. Tardive dyskinesia: therapeutic options for an increasingly common disorder. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 11: 166-76. PMID 24310603 DOI: 10.1007/s13311-013-0222-5  1
2014 Payami H, Factor SA. Promise of pharmacogenomics for drug discovery, treatment and prevention of Parkinson's disease. A perspective. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 11: 111-6. PMID 24258196 DOI: 10.1007/s13311-013-0237-y  1
2014 Alcalay RN, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Orbe Reilly M, Ruiz D, Louis ED, Comella CL, Nance MA, Bressman SB, Scott WK, Tanner CM, Mickel SF, Waters CH, ... ... Factor SA, et al. Cognitive and motor function in long-duration PARKIN-associated Parkinson disease. Jama Neurology. 71: 62-7. PMID 24190026 DOI: 10.1001/jamaneurol.2013.4498  1
2014 Long JD, Paulsen JS, Marder K, Zhang Y, Kim JI, Mills JA. Tracking motor impairments in the progression of Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 311-9. PMID 24150908 DOI: 10.1002/mds.25657  1
2014 Scullin MK, Harrison TL, Factor SA, Bliwise DL. A Neurodegenerative Disease Sleep Questionnaire: principal component analysis in Parkinson's disease. Journal of the Neurological Sciences. 336: 243-6. PMID 24074551 DOI: 10.1016/j.jns.2013.09.009  1
2014 Younes L, Ratnanather JT, Brown T, Aylward E, Nopoulos P, Johnson H, Magnotta VA, Paulsen JS, Margolis RL, Albin RL, Miller MI, Ross CA. Regionally selective atrophy of subcortical structures in prodromal HD as revealed by statistical shape analysis. Human Brain Mapping. 35: 792-809. PMID 23281100 DOI: 10.1002/hbm.22214  1
2013 Wissemann WT, Hill-Burns EM, Zabetian CP, Factor SA, Patsopoulos N, Hoglund B, Holcomb C, Donahue RJ, Thomson G, Erlich H, Payami H. Association of Parkinson disease with structural and regulatory variants in the HLA region. American Journal of Human Genetics. 93: 984-93. PMID 24183452 DOI: 10.1016/j.ajhg.2013.10.009  1
2013 Tiderington E, Goodman EM, Rosen AR, Hapner ER, Johns MM, Evatt ML, Freeman A, Factor S, Jinnah HA. How long does it take to diagnose cervical dystonia? Journal of the Neurological Sciences. 335: 72-4. PMID 24034410 DOI: 10.1016/j.jns.2013.08.028  1
2013 Jinnah HA, Berardelli A, Comella C, Defazio G, Delong MR, Factor S, Galpern WR, Hallett M, Ludlow CL, Perlmutter JS, Rosen AR. The focal dystonias: current views and challenges for future research. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 926-43. PMID 23893450 DOI: 10.1002/mds.25567  1
2013 Scullin MK, Sollinger AB, Land J, Wood-Siverio C, Zanders L, Lee R, Freeman A, Goldstein FC, Bliwise DL, Factor SA. Sleep and impulsivity in Parkinson's disease. Parkinsonism & Related Disorders. 19: 991-4. PMID 23880026 DOI: 10.1016/j.parkreldis.2013.06.018  1
2013 Khooshnoodi MA, Factor SA, Jinnah HA. Secondary blepharospasm associated with structural lesions of the brain. Journal of the Neurological Sciences. 331: 98-101. PMID 23747003 DOI: 10.1016/j.jns.2013.05.022  1
2013 Silver M, Factor SA. Valproic acid-induced parkinsonism: levodopa responsiveness with dyskinesia. Parkinsonism & Related Disorders. 19: 758-60. PMID 23632325 DOI: 10.1016/j.parkreldis.2013.03.016  1
2013 Seegal RF, Fitzgerald EF, McCaffrey RJ, Shrestha S, Hills EA, Wolff MS, Haase RF, Todd AC, Parsons PJ, Molho ES, Higgins DS, Factor SA, Seibyl JP. Tibial bone lead, but not serum polychlorinated biphenyl, concentrations are associated with neurocognitive deficits in former capacitor workers. Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 55: 552-62. PMID 23618890 DOI: 10.1097/JOM.0b013e318285f3fd  1
2013 Factor SA, Wolski K, Togasaki DM, Huyck S, Cantillon M, Ho TW, Hauser RA, Pourcher E. Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 817-20. PMID 23589371 DOI: 10.1002/mds.25395  1
2013 Fuchs T, Saunders-Pullman R, Masuho I, Luciano MS, Raymond D, Factor S, Lang AE, Liang TW, Trosch RM, White S, Ainehsazan E, Hervé D, Sharma N, Ehrlich ME, Martemyanov KA, et al. Mutations in GNAL cause primary torsion dystonia Nature Genetics. 45: 88-92. PMID 23222958 DOI: 10.1038/ng.2496  1
2013 Hill-Burns EM, Singh N, Ganguly P, Hamza TH, Montimurro J, Kay DM, Yearout D, Sheehan P, Frodey K, McLear JA, Feany MB, Hanes SD, Wolfgang WJ, Zabetian CP, Factor SA, et al. A genetic basis for the variable effect of smoking/nicotine on Parkinson's disease. The Pharmacogenomics Journal. 13: 530-7. PMID 23032990 DOI: 10.1038/tpj.2012.38  1
2013 Bliwise DL, Trotti LM, Juncos JJ, Factor SA, Freeman A, Rye DB. Daytime REM sleep in Parkinson's disease. Parkinsonism & Related Disorders. 19: 101-3. PMID 22939103 DOI: 10.1016/j.parkreldis.2012.08.003  1
2013 Factor SA, Reich SG. In Memoriam: William J. Weiner, MD: June 28, 1945-December 29, 2012 Parkinsonism and Related Disorders. 19: 277-278. DOI: 10.1016/j.parkreldis.2013.01.005  1
2013 Molho ES, Factor SA. Psychosis Milestones in Drug Therapy. 24: 63-90. DOI: 10.1007/978-1-60761-429-6_5  1
2012 Factor SA. Propranolol therapy for tardive dyskinesia revisited. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1703. PMID 23192928 DOI: 10.1002/mds.25231  1
2012 Cloud LJ, Rosenblatt A, Margolis RL, Ross CA, Pillai JA, Corey-Bloom J, Tully HM, Bird T, Panegyres PK, Nichter CA, Higgins DS, Helmers SL, Factor SA, Jones R, Testa CM. Seizures in juvenile Huntington's disease: frequency and characterization in a multicenter cohort. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1797-800. PMID 23124580 DOI: 10.1002/mds.25237  1
2012 Revuelta GJ, Uthayathas S, Wahlquist AE, Factor SA, Papa SM. Non-human primate FOG develops with advanced parkinsonism induced by MPTP Treatment. Experimental Neurology. 237: 464-9. PMID 22967858 DOI: 10.1016/j.expneurol.2012.07.021  1
2012 Bliwise DL, Trotti LM, Wilson AG, Greer SA, Wood-Siverio C, Juncos JJ, Factor SA, Freeman A, Rye DB. Daytime alertness in Parkinson's disease: potentially dose-dependent, divergent effects by drug class. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1118-24. PMID 22753297 DOI: 10.1002/mds.25082  1
2012 Yeang CH, Ma GC, Shih JC, Yang YS, Chen CP, Chang SP, Wu SH, Liu CS, Kuo SJ, Chou HC, Hwu WL, Cameron AD, Ginsberg NA, Lin YS, Chen M. Genome-wide gene expression analysis implicates the immune response and lymphangiogenesis in the pathogenesis of fetal chylothorax. Plos One. 7: e34901. PMID 22529953 DOI: 10.1371/journal.pone.0034901  1
2012 Richard IH, McDermott MP, Kurlan R, Lyness JM, Como PG, Pearson N, Factor SA, Juncos J, Serrano Ramos C, Brodsky M, Manning C, Marsh L, Shulman L, Fernandez HH, Black KJ, et al. A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. Neurology. 78: 1229-36. PMID 22496199 DOI: 10.1212/WNL.0b013e3182516244  1
2012 Pankratz N, Beecham GW, DeStefano AL, Dawson TM, Doheny KF, Factor SA, Hamza TH, Hung AY, Hyman BT, Ivinson AJ, Krainc D, Latourelle JC, Clark LN, Marder K, Martin ER, et al. Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2. Annals of Neurology. 71: 370-84. PMID 22451204 DOI: 10.1002/ana.22687  1
2012 Alcalay RN, Caccappolo E, Mejia-Santana H, Tang M-, Rosado L, Orbe Reilly M, Ruiz D, Ross B, Verbitsky M, Kisselev S, Louis E, Comella C, Colcher A, Jennings D, Nance M, ... ... Factor S, et al. Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study. Neurology. 78: 1434-40. PMID 22442429 DOI: 10.1212/WNL.0b013e318253d54b  1
2012 Lill CM, Roehr JT, McQueen MB, Kavvoura FK, Bagade S, Schjeide BM, Schjeide LM, Meissner E, Zauft U, Allen NC, Liu T, Schilling M, Anderson KJ, Beecham G, Berg D, ... ... Factor SA, et al. Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. Plos Genetics. 8: e1002548. PMID 22438815 DOI: 10.1371/journal.pgen.1002548  1
2012 Goldman SM, Kamel F, Ross GW, Jewell SA, Bhudhikanok GS, Umbach D, Marras C, Hauser RA, Jankovic J, Factor SA, Bressman S, Lyons KE, Meng C, Korell M, Roucoux DF, et al. Head injury, α-synuclein Rep1, and Parkinson's disease. Annals of Neurology. 71: 40-8. PMID 22275250 DOI: 10.1002/ana.22499  1
2012 Revuelta GJ, Benatar M, Freeman A, Wichmann T, Jinnah HA, DeLong MR, Factor SA. Clinical subtypes of anterocollis in parkinsonian syndromes. Journal of the Neurological Sciences. 315: 100-3. PMID 22133481 DOI: 10.1016/j.jns.2011.11.017  1
2012 Smith Y, Wichmann T, Factor SA, DeLong MR. Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 213-46. PMID 21956442 DOI: 10.1038/npp.2011.212  1
2012 Revuelta GJ, Cloud L, Aia PG, Factor SA. Tardive Dyskinesias Hyperkinetic Movement Disorders: Differential Diagnosis and Treatment. 331-352. DOI: 10.1002/9781444346183.ch21  1
2011 Hill-Burns EM, Factor SA, Zabetian CP, Thomson G, Payami H. Evidence for more than one Parkinson's disease-associated variant within the HLA region. Plos One. 6: e27109. PMID 22096524 DOI: 10.1371/journal.pone.0027109  1
2011 Marek K, Jennings D, Lasch S, Siderowf A, Tanner C, Simuni T, Coffey C, Kieburtz K, Flagg E, Chowdhury S, Poewe W, Mollenhauer B, Sherer T, Frasier M, Meunier C, ... ... Factor S, et al. The Parkinson Progression Marker Initiative (PPMI) Progress in Neurobiology. 95: 629-635. PMID 21930184 DOI: 10.1016/j.pneurobio.2011.09.005  1
2011 Hill-Burns EM, Hamza TH, Zabetian CP, Factor SA, Payami H. An attempt to replicate interaction between coffee and CYP1A2 gene in connection to Parkinson's disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 18: e107-8; author reply. PMID 21834891 DOI: 10.1111/j.1468-1331.2011.03464.x  1
2011 Factor SA, Steenland NK, Higgins DS, Molho ES, Kay DM, Montimurro J, Rosen AR, Zabetian CP, Payami H. Disease-related and genetic correlates of psychotic symptoms in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 2190-5. PMID 21714002 DOI: 10.1002/mds.23806  1
2011 Robottom BJ, Factor SA, Weiner WJ. Movement disorders emergencies Part 2: hyperkinetic disorders. Archives of Neurology. 68: 719-24. PMID 21670395 DOI: 10.1001/archneurol.2011.117  1
2011 Richardson JR, Roy A, Shalat SL, Buckley B, Winnik B, Gearing M, Levey AI, Factor SA, O'Suilleabhain P, German DC. β-Hexachlorocyclohexane levels in serum and risk of Parkinson's disease. Neurotoxicology. 32: 640-5. PMID 21620887 DOI: 10.1016/j.neuro.2011.04.002  1
2011 Robottom BJ, Weiner WJ, Factor SA. Movement disorders emergencies. Part 1: Hypokinetic disorders. Archives of Neurology. 68: 567-72. PMID 21555633 DOI: 10.1001/archneurol.2011.84  1
2011 Huddleston DE, Factor SA. Of monkeys and men: analysis of the phase 2 double-blind, sham-surgery controlled, randomized trial of AAV2-neurturin gene therapy for Parkinson's disease. Current Neurology and Neuroscience Reports. 11: 345-8. PMID 21505812 DOI: 10.1007/s11910-011-0206-y  1
2011 Evatt ML, Freeman A, Factor S. Adult-onset dystonia. Handbook of Clinical Neurology. 100: 481-511. PMID 21496604 DOI: 10.1016/B978-0-444-52014-2.00037-9  1
2011 Aia PG, Revuelta GJ, Cloud LJ, Factor SA. Tardive dyskinesia. Current Treatment Options in Neurology. 13: 231-41. PMID 21365202 DOI: 10.1007/s11940-011-0117-x  1
2011 Factor SA, Steenland NK, Higgins DS, Molho ES, Kay DM, Montimurro J, Rosen AR, Zabetian CP, Payami H. Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: an exploratory analysis. Journal of Neurology, Neurosurgery, and Psychiatry. 82: 564-8. PMID 20884673 DOI: 10.1136/jnnp.2010.222042  1
2011 Seegal RF, Fitzgerald EF, Hills EA, Wolff MS, Haase RF, Todd AC, Parsons P, Molho ES, Higgins DS, Factor SA, Marek KL, Seibyl JP, Jennings DL, McCaffrey RJ. Estimating the half-lives of PCB congeners in former capacitor workers measured over a 28-year interval. Journal of Exposure Science & Environmental Epidemiology. 21: 234-46. PMID 20216575 DOI: 10.1038/jes.2010.3  1
2010 Cheng EM, Tonn S, Swain-Eng R, Factor SA, Weiner WJ, Bever CT. Quality improvement in neurology: AAN Parkinson disease quality measures: report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology. Neurology. 75: 2021-7. PMID 21115958 DOI: 10.1212/WNL.0b013e3181ff96dd  1
2010 Mata IF, Shi M, Agarwal P, Chung KA, Edwards KL, Factor SA, Galasko DR, Ginghina C, Griffith A, Higgins DS, Kay DM, Kim H, Leverenz JB, Quinn JF, Roberts JW, et al. SNCA variant associated with Parkinson disease and plasma alpha-synuclein level. Archives of Neurology. 67: 1350-6. PMID 21060011 DOI: 10.1001/archneurol.2010.279  1
2010 Kay DM, Stevens CF, Hamza TH, Montimurro JS, Zabetian CP, Factor SA, Samii A, Griffith A, Roberts JW, Molho ES, Higgins DS, Gancher S, Moses L, Zareparsi S, Poorkaj P, et al. A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2. Neurology. 75: 1189-94. PMID 20876472 DOI: 10.1212/WNL.0b013e3181f4d832  1
2010 Hamza TH, Zabetian CP, Tenesa A, Laederach A, Montimurro J, Yearout D, Kay DM, Doheny KF, Paschall J, Pugh E, Kusel VI, Collura R, Roberts J, Griffith A, Samii A, ... ... Factor SA, et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nature Genetics. 42: 781-5. PMID 20711177 DOI: 10.1038/ng.642  1
2010 Esper CD, Freeman A, Factor SA. Lingual protrusion dystonia: frequency, etiology and botulinum toxin therapy. Parkinsonism & Related Disorders. 16: 438-41. PMID 20494607 DOI: 10.1016/j.parkreldis.2010.04.007  1
2010 Sethi K, Factor S, Watts R. Quality of life in parkinson's disease patients following adjunctive tolcapone therapy: Results of an open-label, multicenter, community-based trial Cns Spectrums. 15: 27-32. PMID 20394182  1
2010 Factor S, Mark MH, Watts R, Struck L, Mori A, Ballerini R, Sussman NM. A long-term study of istradefylline in subjects with fluctuating Parkinson's disease Parkinsonism and Related Disorders. 16: 423-426. PMID 20338800 DOI: 10.1016/j.parkreldis.2010.02.014  1
2010 Kieburtz K, McDermott MP, Voss TS, Corey-Bloom J, Deuel LM, Dorsey ER, Factor S, Geschwind MD, Hodgeman K, Kayson E, Noonberg S, Pourfar M, Rabinowitz K, Ravina B, Sanchez-Ramos J, et al. A randomized, placebo-controlled trial of latrepirdine in Huntington disease. Archives of Neurology. 67: 154-60. PMID 20142523 DOI: 10.1001/archneurol.2009.334  1
2010 Seegal RF, Marek KL, Seibyl JP, Jennings DL, Molho ES, Higgins DS, Factor SA, Fitzgerald EF, Hills EA, Korrick SA, Wolff MS, Haase RF, Todd AC, Parsons P, McCaffrey RJ. Occupational exposure to PCBs reduces striatal dopamine transporter densities only in women: a beta-CIT imaging study. Neurobiology of Disease. 38: 219-25. PMID 20096358 DOI: 10.1016/j.nbd.2010.01.009  1
2010 Sollinger AB, Goldstein FC, Lah JJ, Levey AI, Factor SA. Mild cognitive impairment in Parkinson's disease: subtypes and motor characteristics. Parkinsonism & Related Disorders. 16: 177-80. PMID 19939721 DOI: 10.1016/j.parkreldis.2009.11.002  1
2010 Payami H, Kay DM, Zabetian CP, Schellenberg GD, Factor SA, McCulloch CC. Visualizing disease associations: graphic analysis of frequency distributions as a function of age using moving average plots (MAP) with application to Alzheimer's and Parkinson's disease. Genetic Epidemiology. 34: 92-9. PMID 19582778 DOI: 10.1002/gepi.20439  1
2009 Tanner CM, Ross GW, Jewell SA, Hauser RA, Jankovic J, Factor SA, Bressman S, Deligtisch A, Marras C, Lyons KE, Bhudhikanok GS, Roucoux DF, Meng C, Abbott RD, Langston JW. Occupation and risk of parkinsonism: a multicenter case-control study. Archives of Neurology. 66: 1106-13. PMID 19752299 DOI: 10.1001/archneurol.2009.195  1
2009 Lungu C, Aia PG, Shih LC, Esper CD, Factor SA, Tarsy D. Tardive dyskinesia due to aripiprazole: report of 2 cases. Journal of Clinical Psychopharmacology. 29: 185-6. PMID 19512985 DOI: 10.1097/JCP.0b013e31819a4bd5  1
2009 Trotti LM, Esper CD, Feustel PJ, Bliwise DL, Factor SA. Excessive daytime sleepiness in cervical dystonia. Parkinsonism & Related Disorders. 15: 784-6. PMID 19447065 DOI: 10.1016/j.parkreldis.2009.04.007  1
2009 Molho ES, Agarwal N, Regan K, Higgins DS, Factor SA. Effect of cervical dystonia on employment: A retrospective analysis of the ability of treatment to restore premorbid employment status. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 1384-7. PMID 19441129 DOI: 10.1002/mds.22622  1
2009 Weiner W, Ahlskog E, Factor S, Suchowersky O, Reich S. Initiating therapy in Parkinson's disease Annals of Neurology. 65: 480-481. PMID 19399873 DOI: 10.1002/ana.21667  1
2008 Factor SA. The clinical spectrum of freezing of gait in atypical parkinsonism. Movement Disorders : Official Journal of the Movement Disorder Society. 23: S431-8. PMID 18668624 DOI: 10.1002/mds.21849  1
2008 Frank S, Ondo W, Fahn S, Hunter C, Oakes D, Plumb S, Marshall F, Shoulson I, Eberly S, Walker F, Factor S, Hunt V, Shinaman A, Jankovic J. A study of chorea after tetrabenazine withdrawal in patients with Huntington disease. Clinical Neuropharmacology. 31: 127-33. PMID 18520979 DOI: 10.1097/WNF.0b013e3180ca77ea  1
2008 Kay DM, Factor SA, Samii A, Higgins DS, Griffith A, Roberts JW, Leis BC, Nutt JG, Montimurro JS, Keefe RG, Atkins AJ, Yearout D, Zabetian CP, Payami H. Genetic association between alpha-synuclein and idiopathic Parkinson's disease. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 147: 1222-30. PMID 18404644 DOI: 10.1002/ajmg.b.30758  1
2008 Factor SA. Current status of symptomatic medical therapy in Parkinson's disease. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 5: 164-80. PMID 18394561 DOI: 10.1016/j.nurt.2007.12.001  1
2008 Delong MR, Factor SA. Advanced therapies for movement disorders in neurotherapeutics. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 5: 163. PMID 18394560 DOI: 10.1016/j.nurt.2008.02.005  1
2008 McCulloch CC, Kay DM, Factor SA, Samii A, Nutt JG, Higgins DS, Griffith A, Roberts JW, Leis BC, Montimurro JS, Zabetian CP, Payami H. Exploring gene-environment interactions in Parkinson's disease. Human Genetics. 123: 257-65. PMID 18210157 DOI: 10.1007/s00439-008-0466-z  1
2008 Hutter CM, Samii A, Factor SA, Nutt JG, Higgins DS, Bird TD, Griffith A, Roberts JW, Leis BC, Montimurro JS, Kay DM, Edwards KL, Payami H, Zabetian CP. Lack of evidence for an association between UCHL1 S18Y and Parkinson's disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 15: 134-9. PMID 18093156 DOI: 10.1111/j.1468-1331.2007.02012.x  1
2008 Esper CD, Factor SA. Failure of recognition of drug-induced parkinsonism in the elderly. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 401-4. PMID 18067180 DOI: 10.1002/mds.21854  1
2008 Powers KM, Kay DM, Factor SA, Zabetian CP, Higgins DS, Samii A, Nutt JG, Griffith A, Leis B, Roberts JW, Martinez ED, Montimurro JS, Checkoway H, Payami H. Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 88-95. PMID 17987647 DOI: 10.1002/mds.21782  1
2008 Factor SA. Neuroleptic Malignant Syndrome Drug Induced Movement Disorders: Second Edition. 174-212. DOI: 10.1002/9780470753217.ch8  1
2008 Factor SA, Lang AE, Weiner WJ. Preface Drug Induced Movement Disorders: Second Edition. xiii-xiv. DOI: 10.1002/9780470753217  1
2008 Esper CD, Aia PG, Cloud LJ, Factor SA. Cramps and Spasms Therapeutics of Parkinson's Disease and Other Movement Disorders. 263-281. DOI: 10.1002/9780470713990.ch17  1
2007 Esper CD, Weiner WJ, Factor SA. Progressive supranuclear palsy. Reviews in Neurological Diseases. 4: 209-16. PMID 18195676  1
2007 Rosen AR, Steenland NK, Hanfelt J, Factor SA, Lah JJ, Levey AI. Evidence of shared risk for Alzheimer's disease and Parkinson's disease using family history. Neurogenetics. 8: 263-70. PMID 17805588 DOI: 10.1007/s10048-007-0100-6  1
2007 Zabetian CP, Hutter CM, Factor SA, Nutt JG, Higgins DS, Griffith A, Roberts JW, Leis BC, Kay DM, Yearout D, Montimurro JS, Edwards KL, Samii A, Payami H. Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease. Annals of Neurology. 62: 137-44. PMID 17514749 DOI: 10.1002/ana.21157  1
2007 Esper CD, Factor SA. Current and future treatments in multiple system atrophy. Current Treatment Options in Neurology. 9: 210-23. PMID 17445499 DOI: 10.1007/BF02938411  1
2007 Pahwa R, Stacy MA, Factor SA, Lyons KE, Stocchi F, Hersh BP, Elmer LW, Truong DD, Earl NL. Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease. Neurology. 68: 1108-15. PMID 17404192 DOI: 10.1212/01.wnl.0000258660.74391.c1  1
2007 Kay DM, Moran D, Moses L, Poorkaj P, Zabetian CP, Nutt J, Factor SA, Yu CE, Montimurro JS, Keefe RG, Schellenberg GD, Payami H. Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients. Annals of Neurology. 61: 47-54. PMID 17187375 DOI: 10.1002/ana.21039  1
2007 Factor SA. Fatal Parkinsonism-hyperpyrexia syndrome in a Parkinson's disease patient while actively treated with deep brain stimulation. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 148-9. PMID 17080464 DOI: 10.1002/mds.21172  1
2007 Pahwa R, Factor SA, Lyons KE, Ondo WG, Gronseth G, Bronte-Stewart H, Hallett M, Miyasaki J, Stevens J, Weiner WJ. Appendix D: Practice parameter: Treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidenced-based review): Report of the Quality Standards Subcommitte of the American Academy of Neurology Continuum Lifelong Learning in Neurology. 13: 177-189.  1
2006 Elbaz A, Nelson LM, Payami H, Ioannidis JP, Fiske BK, Annesi G, Carmine Belin A, Factor SA, Ferrarese C, Hadjigeorgiou GM, Higgins DS, Kawakami H, Krüger R, Marder KS, Mayeux RP, et al. Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study. The Lancet. Neurology. 5: 917-23. PMID 17052658 DOI: 10.1016/S1474-4422(06)70579-8  1
2006 Kay DM, Bird TD, Zabetian CP, Factor SA, Samii A, Higgins DS, Nutt J, Roberts JW, Griffith A, Leis BC, Montimurro JS, Philpott S, Payami H. Validity and utility of a LRRK2 G2019S mutation test for the diagnosis of Parkinson's disease. Genetic Testing. 10: 221-7. PMID 17020475 DOI: 10.1089/gte.2006.10.221  1
2006 Friedman JH, Berman RM, Goetz CG, Factor SA, Ondo WG, Wojcieszek J, Carson WH, Marcus RN. Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 2078-81. PMID 17013906 DOI: 10.1002/mds.21091  1
2006 Zabetian CP, Hutter CM, Yearout D, Lopez AN, Factor SA, Griffith A, Leis BC, Bird TD, Nutt JG, Higgins DS, Roberts JW, Kay DM, Edwards KL, Samii A, Payami H. LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago. American Journal of Human Genetics. 79: 752-8. PMID 16960813 DOI: 10.1086/508025  1
2006 Pahwa R, Factor SA, Lyons KE, Ondo WG, Gronseth G, Bronte-Stewart H, Hallett M, Miyasaki J, Stevens J, Weiner WJ. Practice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 66: 983-95. PMID 16606909 DOI: 10.1212/01.wnl.0000215250.82576.87  1
2006 Factor SA, Higgins DS, Qian J. Primary progressive freezing gait: a syndrome with many causes. Neurology. 66: 411-4. PMID 16476942 DOI: 10.1212/01.wnl.0000196469.52995.ab  1
2006 Huber VC, Mondal T, Factor SA, Seegal RF, Lawrence DA. Serum antibodies from Parkinson's disease patients react with neuronal membrane proteins from a mouse dopaminergic cell line and affect its dopamine expression. Journal of Neuroinflammation. 3: 1. PMID 16426448 DOI: 10.1186/1742-2094-3-1  1
2006 Kay DM, Zabetian CP, Factor SA, Nutt JG, Samii A, Griffith A, Bird TD, Kramer P, Higgins DS, Payami H. Parkinson's disease and LRRK2: frequency of a common mutation in U.S. movement disorder clinics. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 519-23. PMID 16250030 DOI: 10.1002/mds.20751  1
2005 Murphy MA, Friedman JH, Tetrud JW, Factor SA. Neurodegenerative disorders mimicking progressive supranuclear palsy: a report of three cases. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 12: 941-5. PMID 16289932 DOI: 10.1016/j.jocn.2004.10.013  1
2005 Factor SA, Molho ES, Evans S, Feustel PJ. Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 1152-60. PMID 15954134 DOI: 10.1002/mds.20531  1
2005 Factor SA, Qian J, Lava NS, Hubbard JD, Payami H. False-positive SCA8 gene test in a patient with pathologically proven multiple system atrophy. Annals of Neurology. 57: 462-3. PMID 15732096 DOI: 10.1002/ana.20389  1
2004 Factor SA, Molho ES. Threatening auditory hallucinations and Cotard syndrome in Parkinson disease. Clinical Neuropharmacology. 27: 205-7. PMID 15602098 DOI: 10.1097/01.wnf.0000144040.20600.c1  1
2004 Fernandez HH, Friedman JH, Lansang MC, Factor SA, Molho ES, Coskun DJ. Diabetes mellitus among parkinsonian patients treated chronically with clozapine. Parkinsonism & Related Disorders. 10: 439-41. PMID 15465403 DOI: 10.1016/j.parkreldis.2004.04.007  1
2004 Factor SA. Literature review: intermittent subcutaneous apomorphine therapy in Parkinson's disease. Neurology. 62: S12-7. PMID 15037666  1
2003 Factor SA, Troche-Panetto M, Weaver SA. Dystonia in AIDS: report of four cases. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 1492-8. PMID 14673886 DOI: 10.1002/mds.10602  1
2003 Factor SA, Feustel PJ, Friedman JH, Comella CL, Goetz CG, Kurlan R, Parsa M, Pfeiffer R. Longitudinal outcome of Parkinson's disease patients with psychosis. Neurology. 60: 1756-61. PMID 12796526  1
2002 Factor SA, Jennings DL, Molho ES, Marek KL. The natural history of the syndrome of primary progressive freezing gait. Archives of Neurology. 59: 1778-83. PMID 12433266 DOI: 10.1001/archneur.59.11.1778  1
2002 Factor SA. Cervical dystonia in twins. Movement Disorders : Official Journal of the Movement Disorder Society. 17: 846-7. PMID 12210893 DOI: 10.1002/mds.10215  1
2002 Reddy S, Factor SA, Molho ES, Feustel PJ. The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia. Movement Disorders : Official Journal of the Movement Disorder Society. 17: 676-81. PMID 12210856 DOI: 10.1002/mds.10176  1
2002 Factor SA. Pharmacology of atypical antipsychotics. Clinical Neuropharmacology. 25: 153-7. PMID 12023569 DOI: 10.1097/00002826-200205000-00005  1
2002 Factor SA, Molho ES, Friedman JH. Risperidone and Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 17: 221-2. PMID 11835472 DOI: 10.1002/mds.1258  1
2002 Adler CH, Factor SA, Brin M, Sethi KD. Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. 17: 158-61. PMID 11835455 DOI: 10.1002/mds.10001  1
2001 Molho ES, Factor SA. Parkinson's disease: the treatment of drug-induced hallucinations and psychosis. Current Neurology and Neuroscience Reports. 1: 320-8. PMID 11898537  1
2001 Factor SA, Molho ES, Feustel PJ, Brown DL, Evans SM. Long-term comparative experience with tolcapone and entacapone in advanced Parkinson's disease. Clinical Neuropharmacology. 24: 295-9. PMID 11586115 DOI: 10.1097/00002826-200109000-00007  1
2001 Dewey RB, Hutton JT, LeWitt PA, Factor SA. A randomized, double-blind, placebo-controlled trial of subcutaneously injected apomorphine for parkinsonian off-state events Archives of Neurology. 58: 1385-1392. PMID 11559309  1
2001 Factor SA, Lava NS. Focal myopathy as a cause of anterocollis in Parkinsonism Movement Disorders. 16: 754-756. PMID 11481704 DOI: 10.1002/mds.1152  1
2001 Weiner WJ, Factor SA, Jankovic J, Hauser RA, Tetrud JW, Waters CH, Shulman LM, Glassman PM, Beck B, Paume D, Doyle C. The long-term safety and efficacy of pramipexole in advanced Parkinson's disease. Parkinsonism & Related Disorders. 7: 115-120. PMID 11248592 DOI: 10.1016/S1353-8020(00)00031-6  1
2001 Factor SA, Friedman JH, Lannon MC, Oakes D, Bourgeois K. Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: Results of the 12 week open label extension in the PSYCLOPS trial Movement Disorders. 16: 135-139. PMID 11215574 DOI: 10.1002/1531-8257(200101)16:1<135::AID-MDS1006>3.0.CO;2-Q  1
2001 Friedman JH, Fernandez HH, Factor SA, Rangu S, Rowland FN. Treatment of psychosis in parkinson's disease (multiple letters) Journal of the American Medical Directors Association. 2: 99-100.  1
2000 Serrano-Dueñas M, Friedman JH, Factor SA. A typical antipsychotics: Clozapine-related cardiac complications (multiple letters) Movement Disorders. 15: 1300. PMID 11104235  1
2000 Higgins JJ, Golbe LI, De Biase A, Jankovic J, Factor SA, Adler RL. An extended 5'-tau susceptibility haplotype in progressive supranuclear palsy Neurology. 55: 1364-1367. PMID 11087782  1
2000 Weiner WJ, Factor SA. Ropinirole as compared with levodopa in Parkinson's disease. The New England Journal of Medicine. 343: 885. PMID 11001687  1
2000 Hiner BC, Earnhart M, Yamamoto T, Frucht S, Weiner WJ, Factor SA, Rascol O. Ropinirole as compared with levodopa in Parkinson's disease [1] (multiple letters) New England Journal of Medicine. 343: 884-885. PMID 11001685 DOI: 10.1056/NEJM200009213431211  1
2000 Hauser RA, Friedlander J, Zesiewicz TA, Adler CH, Seeberger LC, O'Brien CF, Molho ES, Factor SA. A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesia Clinical Neuropharmacology. 23: 75-81. PMID 10803796 DOI: 10.1097/00002826-200003000-00003  1
2000 Factor SA. The initial treatment of Parkinson's disease (multiple letters) Movement Disorders. 15: 360-362. PMID 10752599 DOI: 10.1002/1531-8257(200003)15:2<360::AID-MDS1033>3.0.CO;2-N  1
2000 Friedman JH, Factor SA. Atypical antipsychotics in the treatment of drug-induced psychosis in parkinson's disease Movement Disorders. 15: 201-211. PMID 10752567 DOI: 10.1002/1531-8257(200003)15:2<201::AID-MDS1001>3.0.CO;2-D  1
2000 Factor SA, Molho ES. Emergency department presentations of patients with Parkinson's disease American Journal of Emergency Medicine. 18: 209-215. PMID 10750935  1
2000 Factor SA, Brown DL, Molho ES. Subcutaneous apomorphine injections as a treatment for intractable pain in Parkinson's disease Movement Disorders. 15: 167-169. PMID 10634261 DOI: 10.1002/1531-8257(200001)15:1<167::AID-MDS1029>3.0.CO;2-8  1
1999 Molho ES, Factor SA. Worsening of motor features of parkinsonism with olanzapine Movement Disorders. 14: 1014-1016. PMID 10584679 DOI: 10.1002/1531-8257(199911)14:6<1014::AID-MDS1017>3.0.CO;2-9  1
1999 Brashear A, Lew MF, Dykstra DD, Comella CL, Factor SA, Rodnitzky RL, Trosch R, Singer C, Brin MF, Murray JJ, Wallace JD, Willmer-Hulme A, Koller M. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A- responsive cervical dystonia Neurology. 53: 1439-1446. PMID 10534248  1
1999 Brin MF, Lew MF, Adler CH, Comella CL, Factor SA, Jankovic J, O'Brien C, Murray JJ, Wallace JD, Willmer-Hulme A, Koller M. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A- resistant cervical dystonia Neurology. 53: 1431-1438. PMID 10534247  1
1999 Molho ES, Factor SA. Possible tardive dystonia resulting from clozapine therapy Movement Disorders. 14: 873-874. PMID 10495056 DOI: 10.1002/1531-8257(199909)14:5<873::AID-MDS1027>3.0.CO;2-U  1
1999 Factor SA, Molho ES. Transient benefit of amantadine in Parkinson's disease: The facts about the myth Movement Disorders. 14: 515-517. PMID 10348482 DOI: 10.1002/1531-8257(199905)14:3<515::AID-MDS1024>3.0.CO;2-Z  1
1999 Miyasaki JM, Grimes D, Lang AE, Factor SA, Molho ES, Brown DL. Acute delirium after withdrawal of amantadine in Parkinson's disease [5] (multiple letters) Neurology. 52: 1720-1721. PMID 10331717  1
1999 Factor SA. Dopamine agonists Medical Clinics of North America. 83: 415-443. PMID 10093586 DOI: 10.1016/S0025-7125(05)70112-7  1
1998 Kompoliti K, Goetz CG, Boeve BF, Maraganore DM, Ahlskog JE, Marsden CD, Bhatia KP, Greene PE, Przedborski S, Seal EC, Burns RS, Hauser RA, Gauger LL, Factor SA, Molho ES, et al. Clinical presentation and pharmacological therapy in corticobasal degeneration Archives of Neurology. 55: 957-961. PMID 9678313 DOI: 10.1001/archneur.55.7.957  1
1998 Molho ES, Feustel PJ, Factor SA. Clinical comparison of tardive and idiopathic cervical dystonia Movement Disorders. 13: 486-489. PMID 9613742 DOI: 10.1002/mds.870130319  1
1998 Factor SA, Weiner WJ. 'Sleep benefit' in Parkinson's disease. Neurology. 50: 1514-5. PMID 9596032  1
1998 Kieburtz K, Frey K, Albin R, Marek K, Bates G, Aylward E, Guttman M, Rouleau G, Baehr M, Pahwa R, Lyons KE, Wilkinson SB, Kieltyka J, Koller WC, Bertoni JM, ... ... Factor SA, et al. Twelfth Annual Symposia on Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Etiology, Pathogenesis, and Treatment of Huntington's Disease, Queen Elizabeth Hotel, Montreal, Canada, 18 October 1998 Movement Disorders. 13: 858-863. DOI: 10.1002/mds.870130522  1
1997 Hauser RA, Zesiewicz TA, Factor SA, Guttman M, Weiner WJ. Clinical trials of add-on medications in Parkinson's disease: Efficacy versus usefulness. Parkinsonism & Related Disorders. 3: 1-6. PMID 18591048 DOI: 10.1016/S1353-8020(96)00042-9  1
1997 Factor SA, Molho ES. Adult-onset tics associated with peripheral injury Movement Disorders. 12: 1052-1055. PMID 9399236 DOI: 10.1002/mds.870120634  1
1997 Factor SA, Barron KD. Mosaic pattern of gliosis in the neostriatum of a North American man with craniocervical dystonia and parkinsonism. Movement Disorders : Official Journal of the Movement Disorder Society. 12: 783-9. PMID 9380067 DOI: 10.1002/mds.870120528  1
1997 Lew MF, Adornato BT, Duane DD, Dykstra DD, Factor SA, Massey JM, Brin MF, Jankovic J, Rodnitzky RL, Singer C, Swenson MR, Tarsy D, Murray JJ, Koller M, Wallace JD. Botulinum toxin type b: A double-blind, placebo controlled, safety and efficacy study in cervical dystonia Neurology. 49: 701-707. PMID 9305326  1
1997 Factor SA, Friedman JH. The emerging role of clozapine in the treatment of improvement disorders Movement Disorders. 12: 483-496. PMID 9251065 DOI: 10.1002/mds.870120403  1
1996 Podskalny GD, Factor SA. Chorea caused by lithium intoxication: A case report and literature review Movement Disorders. 11: 733-737. PMID 8914104 DOI: 10.1002/mds.870110623  1
1996 Molho ES, Factor SA, Podskalny GD, Brown D. The effect of dancing on dystonia Movement Disorders. 11: 225-227. PMID 8684398 DOI: 10.1002/mds.870110220  1
1995 Molho ES, Factor SA, Weiner WJ, Sanchez-Ramos JR, Singer C, Shulman L, Brown D, Sheldon C. The use of pramipexole, a novel dopamine (DA) agonist, in advanced Parkinson's disease. Journal of Neural Transmission. Supplementum. 45: 225-30. PMID 8748629  1
1995 Factor SA, Schneider AS. Peripheral catecholamine output in Parkinson's disease: Effects of drug treatment Experimental Neurology. 131: 64-68. PMID 7895813 DOI: 10.1016/0014-4886(95)90008-X  1
1995 Factor SA, Molho ES, Podskalny GD, Brown D. Parkinson's disease: drug-induced psychiatric states Advances in Neurology. 65: 115-138. PMID 7872135  1
1995 Factor SA, Molho ES, Brown DL. Combined clozapine and electroconvulsive therapy for the treatment of drug-induced psychosis in Parkinson's disease Journal of Neuropsychiatry and Clinical Neurosciences. 7: 304-307. PMID 7580188  1
1995 Factor SA, Podskalny GD, Molho ES. Psychogenic movement disorders: Frequency, clinical profile, and characteristics Journal of Neurology, Neurosurgery and Psychiatry. 59: 406-412. PMID 7561921 DOI: 10.1136/jnnp.59.4.406  1
1994 Koller WC, Busenbark K, Miner K. The relationship of essential tremor to other movement disorders: report on 678 patients. Essential Tremor Study Group. Annals of Neurology. 35: 717-23. PMID 8210229 DOI: 10.1002/ana.410350613  1
1994 Factor SA, Ortof E, Dentinger MP, Mankes R, Barron KD. Platelet morphology in Parkinson's disease: an electron microscopic study. Journal of the Neurological Sciences. 122: 84-9. PMID 8195808 DOI: 10.1016/0022-510X(94)90056-6  1
1994 Factor SA, Brown D, Molho ES, Podskalny GD. Clozapine: A 2-year open trial in parkinson’s disease patients with psychosis Neurology. 44: 544-546. PMID 8145929  1
1994 Factor SA, Podskalny GD, Barron KD. Persistent neuroleptic-induced rigidity and dystonia in AIDS dementia complex: a clinico-pathological case report. Journal of the Neurological Sciences. 127: 114-20. PMID 7699386 DOI: 10.1016/0022-510X(94)90144-9  1
1993 Factor SA. Acetazolamide therapy of menstrual-related fluctuations in Parkinson's disease Movement Disorders. 8: 240-241. PMID 8474504  1
1993 Molho ES, Factor SA. Basal ganglia infarction as a possible cause of cervical dystonia Movement Disorders. 8: 213-216. PMID 8474493  1
1993 Weiner WJ, Factor SA, Sanchez-Ramos JR, Singer C, Sheldon C, Cornelius L, Ingenito A. Early combination therapy (bromocriptine and levodopa) does not prevent motor fluctuations in Parkinson's disease. Neurology. 43: 21-7. PMID 8423888  1
1993 Factor SA, Weiner WJ. Early combination therapy with bromocriptine and levodopa in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 8: 257-62. PMID 8341289 DOI: 10.1002/mds.870080302  1
1992 Factor SA, Brown D. Clozapine prevents recurrence of psychosis in Parkinson's disease Movement Disorders. 7: 125-131. PMID 1350059  1
1991 Factor SA, Coni RJ, Cowger M, Rosenblum EL. Paroxysmal tremor and orofacial dyskinesia secondary to a biopterin synthesis defect Neurology. 41: 930-932. PMID 2046945  1
1991 Factor SA, Matthews MK. Persistent extrapyramidal syndrome with dystonia and rigidity caused by combined metoclopramide and prochlorperazine therapy Southern Medical Journal. 84: 626-628. PMID 2035085  1
1991 Tolge CF, Factor SA. Focal dystonia secondary to cerebral toxoplasmosis in a patient with acquired immune deficiency syndrome Movement Disorders. 6: 69-72. PMID 2005925 DOI: 10.1002/mds.870060113  1
1991 Factor SA, Weiner WJ. Prior history of head trauma in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 6: 225-9. PMID 1922127 DOI: 10.1002/mds.870060306  1
1990 Factor SA. Head tremor after a remission of spasmodic torticollis Movement Disorders. 5: 353-354. PMID 2259364  1
1990 Factor SA, McAlarney T, Sanchez-Ramos JR, Weiner WJ. Sleep disorders and sleep effect in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 5: 280-5. PMID 2259351 DOI: 10.1002/mds.870050404  1
1990 Factor SA, Sanchez-Ramos JR, Weiner WJ. Vitamin E therapy in Parkinson's disease. Advances in Neurology. 53: 457-61. PMID 2239484  1
1989 Sanchez-Ramos JR, Factor SA, Weiner WJ, Marquez J. Hemichorea-hemiballismus associated with acquired immune deficiency syndrome and cerebral toxoplasmosis. Movement Disorders : Official Journal of the Movement Disorder Society. 4: 266-73. PMID 2779596 DOI: 10.1002/mds.870040308  1
1989 Factor SA, Weiner WJ, Hefti F. Acetaminophen metabolism by cytochrome P450 monooxygenases in Parkinson's disease. Annals of Neurology. 26: 286-8. PMID 2774516 DOI: 10.1002/ana.410260219  1
1989 Weiner WJ, Factor SA, Sanchez-Ramos JR. The efficacy of (+)-4-propyl-9-hydroxynaphthoxazine as adjunctive therapy in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 52: 732-5. PMID 2746265  1
1989 Factor SA, Sanchez-Ramos JR, Weiner WJ, Ingenito AM. Efficacy of sinemet CR4 in subgroups of patients with Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 52: 83-8. PMID 2709040  1
1989 Factor SA, Weiner WJ. Retrospective evaluation of vitamin E therapy in Parkinson's disease Annals of the New York Academy of Sciences. 570: 441-442.  1
1988 Factor SA, Sanchez-Ramos JR, Weiner WJ. Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapy. Journal of Neurology, Neurosurgery, and Psychiatry. 51: 529-33. PMID 3288717  1
1988 Factor SA, Sanchez-Ramos JR, Weiner WJ. Cocaine and Tourette's syndrome. Annals of Neurology. 23: 423-4. PMID 3164176 DOI: 10.1002/ana.410230430  1
1988 Factor SA, Sanchez-Ramos J, Weiner WJ. Delayed-onset dystonia associated with corticospinal tract dysfunction. Movement Disorders : Official Journal of the Movement Disorder Society. 3: 201-10. PMID 3057351 DOI: 10.1002/mds.870030304  1
1988 Factor SA, Sanchez-Ramos J, Weiner WJ. Trauma as an etiology of parkinsonism: a historical review of the concept. Movement Disorders : Official Journal of the Movement Disorder Society. 3: 30-6. PMID 3050470 DOI: 10.1002/mds.870030105  1
1987 Factor SA, Sanchez-Ramos J, Weiner WJ, Lieberman A, Koslow M, Maestrone P, White RJ, Venna N, Sabin TD, Osserman EF, Drucker-Colin R, Madrazo-Navarro I. Adrenal grafts for Parkinson's disease New England Journal of Medicine. 317: 1091-1093. PMID 3657873  1
1987 Weiner WJ, Factor SA, Sanchez-Ramos J, Berger J. A double-blind evaluation of ciladopa in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 2: 211-7. PMID 3332914 DOI: 10.1002/mds.870020308  1
Show low-probability matches.